Literature DB >> 19999360

Endoscopic resection of juvenile nasopharyngeal angiofibroma.

Johnson Huang1, Raymond Sacks, Martin Forer.   

Abstract

OBJECTIVES: A 2-surgeon technique has been proposed that allows resection of juvenile nasopharyngeal angiofibroma (JNA) with extension into the infratemporal fossa by utilizing a septal incision for passage of a retracting instrument from the opposite nostril. This technique, however, does not overcome the problem of limited space within the nasal cavity for the tumor to be retracted. Therefore, the tumor has to be divided to allow for its removal. We are proposing a different 2-surgeon technique as an alternative operative technique for the resection of JNA.
METHODS: A new technique of endoscopic resection of JNA involves a transseptal posterior perforation. This perforation allows retraction of the tumor into the opposite nasal cavity by the second surgeon. The retraction of the tumor creates space for its resection.
RESULTS: Nineteen patients (all male) underwent this 2-surgeon technique for resection of JNA. The follow-up period ranged up to 9 years, and no recurrence was recorded.
CONCLUSIONS: Longer-term follow-up is needed to assess recurrence rate and morbidity with this technique. However, in our small series, the 2-surgeon technique via posterior septal perforation was associated with low morbidity and recurrence rates.

Entities:  

Mesh:

Year:  2009        PMID: 19999360

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  Nasopharyngeal Angiofibroma: Paradigm Shift in Management.

Authors:  Manzoor Ahmad Latoo; Waqar Ul Hamid; Aleena Shafi Jallu; Mudasir Ul Islam; Rafiq Ahmad Pampori
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-01-04

2.  Endoscopic endonasal transturbinate approach to the pterygopalatine fossa in the management of juvenile nasopharyngeal angiofibromas.

Authors:  Satoru Kodama; Hideaki Mabuchi; Masashi Suzuki
Journal:  Case Rep Otolaryngol       Date:  2012-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.